VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
DSM-Firmenich AG vs GSK plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
DSM-Firmenich AG
DSFIR · Euronext Amsterdam
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into DSM-Firmenich AG's moat claims, evidence, and risks.
View DSFIR analysisGSK plc
GSK · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: DSM-Firmenich AG leads (63 / 100 vs 62 / 100 for GSK plc).
- Segment focus: DSM-Firmenich AG has 4 segments (31% in Perfumery & Beauty); GSK plc has 3 segments (37.6% in Specialty Medicines).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: DSM-Firmenich AG has 10 moat types across 4 domains; GSK plc has 4 across 3.
Primary market context
DSM-Firmenich AG
Perfumery & Beauty
B2B fragrances, perfumery ingredients, and beauty ingredients
Global
Consumer brands (fine fragrance, personal care, home care) and beauty brands
Ingredient supplier / fragrance house (co-creation + ingredient palette)
31%
GSK plc
Specialty Medicines
Branded specialty pharmaceuticals (HIV, oncology, immunology/respiratory)
Global
Hospitals, specialist physicians, payers
Innovator & branded manufacturer
37.6%
Side-by-side metrics
Moat coverage
Shared moat types
DSM-Firmenich AG strengths
GSK plc strengths
Segment mix
DSM-Firmenich AG segments
Full profile >Perfumery & Beauty
Oligopoly
Taste, Texture & Health
Oligopoly
Health, Nutrition & Care
Competitive
Animal Nutrition & Health
Competitive
GSK plc segments
Full profile >Vaccines
Oligopoly
Specialty Medicines
Oligopoly
General Medicines
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.